This inventor holds 1 USPTO granted patent. Top assignee: Bioagency Ag. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Mathias Eberl: Innovator in Organophosphorous Compounds
Introduction
Mathias Eberl is a notable inventor based in Giessen, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of organophosphorous compounds. His work focuses on the activation of gamma/delta T cells, which has important implications for medical treatments.
Latest Patents
Eberl holds a patent for "Organophosphorous compounds for the activation of gamma/delta T cells." This invention describes organophosphorus compounds of general formula (I), their preparation, and their uses in the activation of gamma/delta T-cells. The patent also covers the screening of GcpE and LytB enzyme inhibitors, as well as the prophylaxis and treatment of diseases in humans and animals. He has 1 patent to his name.
Career Highlights
Mathias Eberl is associated with Bioagency AG, where he continues to advance his research and development efforts. His work is pivotal in the exploration of new therapeutic avenues in immunology.
Collaborations
Eberl collaborates with talented individuals such as Ann-Kristin Kollas and Hassan Jomaa, contributing to a dynamic research environment.
Conclusion
Mathias Eberl's innovative work in organophosphorous compounds showcases his commitment to advancing medical science. His contributions are vital for the future of immunotherapy and disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile